Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | W | LTM |
|---|---|---|
| Price | $100.21 | $47.86 |
| Change today | ▼ 2.29% | ▼ 4.07% |
| Market cap | $13.73B | $13.74B |
| Return, 3 months | +5.3% | -15.9% |
| Return, year to date | -0.2% | -11.2% |
| Return, 1 year | +16.0% | +12.0% |
| P/E (TTM) | -40.4 | 8.8 |
| P/B | -4.9 | 6.9 |
| P/E percentile vs own 5y | 9th | 31st |
| Dividend yield | – | 3.20% |
| Revenue growth (YoY, latest qtr) | +7.5% | +27.2% |
| Net profit growth (YoY) | -106.7% | -51.2% |
| Gross margin | 30.1% | 27.0% |
| Operating margin | 1.8% | 15.2% |
| Net margin | -2.5% | 9.9% |
| Return on equity | – | 107.3% |
| Analyst target vs. price | +26.7% | +56.7% |
| Analyst buy share | 73% | 100% |
| RSI (14) | 53 | 42 |
| 30-day volatility | 47.4% | 33.1% |
| Max drawdown, 1 year | -51.8% | -33.9% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
